Jasraj Singh

Jasraj Singh

Auto-generated profile, based on publicly available information

Jasraj Singh

Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN (F.W.A., J.S., J.C.M., X.M., H.H.C.).

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2022 in Journal of Clinical Imaging Science
Verified
Journal Article
Open access
ZKZain M Khazi
Zain M Khazi
JMJasraj Marjara
Jasraj Marjara
MNMichael Nance
Michael Nance
YGYezaz A Ghouri
Yezaz A Ghouri
GHGhassan M Hammoud
Ghassan M Hammoud
ABAmbarish Bhat
Ambarish Bhat
Objective: To determine the efficacy of gastroduodenal artery embolization (GDAE) for bleeding peptic ulcers that failed endoscopic intervention. To identify incidence and risk factors for failure of GDAE. Materials and Methods: A retrospective review of patients who underwent GDAE for hemorrhage from peptic ulcer disease refractory to endoscopic intervention were included in the study. Refractory to endoscopic intervention was defined as persistent hemorrhage following at least two separate endoscopic sessions with two different endoscopic techniques (thermal, injection, or mechanical) or one endoscopic session with the use of two different techniques. Demographics, comorbidities, endoscopic and angiographic findings, significant post-embolization pRBC transfusion, and index GDAE failure were collected. Failure of index GDAE was defined as the need for re-intervention (repeat embolization, endoscopy, or surgery) for rebleeding or mortality within 30 days after GDAE. Multivariate analyzes were performed to identify independent predictors for failure of index GDAE. Results: There were 70 patients that underwent GDAE after endoscopic intervention for bleeding peptic ulcers with a technical success rate of 100%. Failure of index GDAE rate was 23% (n = 16). Multivariate analysis identified ≥2 comorbidities (odds ratio [OR]: 14.2 [1.68-19.2], P = 0.023), days between endoscopy and GDAE (OR: 1.43 [1.11-2.27], P = 0.028), and extravasation during angiography (OR: 6.71 [1.16-47.4], P = 0.039) as independent predictors of index GDAE failure. Endoscopic Forrest classification was not a significant predictor for the failure of index GDAE (P > 0.1). Conclusion: The study demonstrates safety and efficacy of GDAE for hemorrhage from PUD that is refractory to endoscopic intervention. Days between endoscopy and GDAE, high comorbidity burden, and extravasation during angiography are associated with increased risk for failure of index GDAE.

25 November 2024 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
JSJasraj Singh
Jasraj Singh
FAFadi W. Adel
Fadi W. Adel
CSChristopher G. Scott
Christopher G. Scott
HCHorng H. Chen
Horng H. Chen

17 March 2025 in Interventional Cardiology: Reviews, Research, Resources
Verified
Journal Article
Open access
PDF file
JSJasraj Singh
Jasraj Singh
NNNewton Neidert
Newton Neidert
JAJason H Anderson
Jason H Anderson
ALAndrew J Layman
Andrew J Layman
KRKaren L Rech
Karen L Rech
MKMatthew J Koster
Matthew J Koster
Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterised by multiorgan pathological histiocytic infiltration. Cardiac involvement occurs in 40–75% of patients and increases mortality. A 55-year-old woman with chest pain and dyspnoea was found to have an interatrial septal mass and aortitis suspicious for ECD without other organ involvement. After two inadequate transcatheter interatrial biopsies were obtained using ultrasound guidance alone, diagnostic samples were successfully obtained using intraprocedural frozen section examination. The patient started genotype-targeted treatment with good response. Biopsy confirmation of ECD is required to guide treatment; however, cardiac biopsies are uncommonly performed when other organs are affected. Our unique case of isolated cardiovascular involvement highlights how frozen sectioning with multimodal intraprocedural imaging guidance can improve diagnostic yield of endomyocardial biopsies. It also highlights how diagnosis of rare conditions requires careful multidisciplinary evaluation of affected organs, procedural risk and diagnostic yield. The use of frozen sectioning can improve diagnostic yield of endomyocardial biopsies.

1 January 2026 in Case Reports in Cardiology
Verified
Journal Article
Open access
JSJasraj Singh
Jasraj Singh
FAFadi W. Adel
Fadi W. Adel
HCHorng H. Chen
Horng H. Chen
Sudden cardiac death (SCD) is a prevalent and significant health concern which may be preceded by palpitations and presyncope in a young patient. Of the arrhythmogenic causes of SCD, arrhythmogenic cardiomyopathy (ACM) is rare but important with a high morbidity and mortality. Here, we present a classic case of biventricular (BiV) ACM in a man in his 30s who presented with progressive palpitations and syncope found to have nonsustained ventricular tachycardia and suspicious cardiac imaging findings. Diagnosis was confirmed according to the 2024 European Task Force Criteria: T wave inversions in V1–V3 without a right bundle branch block (major criterion); regional right ventricular (RV) systolic dyskinesis with both reduced RV systolic function by CMR (RVEF 34% and normal 42%–66%); and enlarged RV by indexed RV EDV by CMR (131 mL/m 2 ) (major criterion). LV global longitudinal strain was reduced on transthoracic echocardiography at −17% (normal more negative than −18%) (minor criterion) and T wave inversions in left precordial leads (V4–V6) (in the absence of complete LBBB) (minor criterion). With timely intervention, including ICD placement and sotalol initiation, the patient made a good recovery. This case serves as a critical reminder that recognizing the subtle yet telling signs of BiV‐ACM can mean the difference between life and sudden cardiac death.

1 November 2026 in Circulation: Heart Failure
Verified
Journal Article
Closed access
FAFadi W. Adel
Fadi W. Adel
BGBenjamin R. Gochanour
Benjamin R. Gochanour
CSChristopher Scott
Christopher Scott
JSJasraj Singh
Jasraj Singh
JMJ.C. Malsawmzuali
J.C. Malsawmzuali
HCHorng H. Chen
Horng H. Chen
BACKGROUND: Although diabetes is a known driver of heart failure with preserved ejection fraction, whether antecedent hyperinsulinemia drives preclinical diastolic dysfunction (DD) progression before overt hyperglycemia remains unknown. Therefore, we investigated whether elevated endogenous insulin and insulin resistance independently predict longitudinal DD progression and adverse cardiovascular outcomes. METHODS: In a community-based cohort study, we evaluated 1191 participants from the Olmsted County Heart Function Study (median age, 58.7 [interquartile range, 52.4–66.6 years]) who underwent echocardiography at baseline and after 4 years. Fasting insulin and homeostatic model assessment of insulin resistance were assessed. The primary end point was DD progression. Secondary outcomes (mortality, heart failure) were assessed in 2030 participants followed for a median of 10.97 (95% CI, 10.90–11.05) years for heart failure and a median of 18.1 (95% CI, 18.0–18.2) years for mortality. RESULTS: DD progression occurred in 7.5% of participants. Baseline fasting insulin and homeostatic model assessment of insulin resistance strongly predicted progression ( P <0.001). In multivariable analysis, every 1-SD increase in log-transformed insulin was associated with 65% increased odds of progression (odds ratio, 1.65 [95% CI, 1.33–2.07]; P <0.001), adjusting for age, creatinine, and NT-proBNP (N-terminal pro-B-type natriuretic peptide). Similar results were observed for homeostatic model assessment of insulin resistance (odds ratio, 1.66 [95% CI, 1.34–2.08]; P <0.001). In secondary analyses, elevated insulin independently predicted all-cause (hazard ratio, 1.11 per 1-SD [95% CI, 1.02–1.21]) and cardiovascular mortality (hazard ratio, 1.16 [95% CI, 1.02–1.33]). Homeostatic model assessment of insulin resistance was similarly predictive of all-cause (hazard ratio, 1.11 [95% CI, 1.03–1.20]) and cardiovascular mortality (hazard ratio, 1.16 [95% CI, 1.02–1.32]). CONCLUSIONS: Elevated endogenous insulin and insulin resistance are predictors of progressive DD and long-term mortality, even after accounting for body mass index. Metabolic dysregulation may drive myocardial stiffening before diabetes onset, identifying a potential early therapeutic window for heart failure with preserved ejection fraction prevention.